CS
NARI

Candriam SCA’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Candriam SCA’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-59,095
Closed -$2.84M – 732
2024
Q1 		$2.84M Buy
+59,095
New +$3.16M 0.02% 446
2023
Q2 		– Sell
-7,713
Closed -$438K – 884
2023
Q1 		$438K Sell
7,713
-5,096
-40% -$306K ﹤0.01% 796
2022
Q4 		$814K Sell
12,809
-1,625
-11% -$118K 0.01% 746
2022
Q3 		$1.05M Buy
+14,434
New +$1.07M 0.01% 695

Other funds holding NARI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Candriam SCA's NARI Position: Q2 2024 in Review

Candriam SCA sold out of Inari Medical, Inc. Common Stock (NARI) in Q2 2024, closing a stake of 59,095 shares — an estimated $2.84M sold.

Candriam SCA first reported a position in NARI in Q3 2022 and held it in 4 quarters. The position peaked at $2.84M in Q1 2024. 243 funds tracked by Wall St. Rank hold NARI as of Q2 2024.

  • Candriam SCA reported no remaining Inari Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Candriam SCA sold 59,095 Inari Medical, Inc. Common Stock shares in Q2 2024, an estimated $2.84M.
  • Candriam SCA first reported a position in Inari Medical, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
  • Candriam SCA's Inari Medical, Inc. Common Stock position peaked at $2.84M in Q1 2024.
  • 243 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2024.

Based on Candriam SCA's 13F filing for Q2 2024, filed 5 Aug 2024.